Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Concord Biotech is a leading global R&D-driven biopharmaceutical company based in India, specializing in the development and manufacture of fermentation-based Active Pharmaceutical Ingredients (APIs). The company is a major global player in the immunosuppressant market, producing critical drugs such as Mycophenolate Mofetil, Tacrolimus, and Cyclosporine used in organ transplantation and autoimmune therapy. Beyond its core API business, Concord has expanded into finished formulations and maintains a diverse portfolio across oncology, anti-fungals, and anti-bacterials. With multiple manufacturing facilities approved by global regulatory bodies including the US FDA and EU GMP, the company serves a broad international client base in over 70 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Concord Museum.